Role of response gene to complement 32 in diseases | springermedizin.at

Springer Medizin Österreich

nach oben

Archivum Immunologiae et Therapiae Experimentalis

Erschienen in:

01.04.2008 | Review

Role of response gene to complement 32 in diseases

verfasst von: Sonia I. Vlaicu, Cornelia Cudrici, Takahiro Ito, Matthew Fosbrink, Cosmin A. Tegla, Violeta Rus, Petru A. Mircea, Horea Rus

Erschienen in: Archivum Immunologiae et Therapiae Experimentalis | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Anzeige

Vorheriger Artikel Current advances in the management of urticaria

Nächster Artikel Live attenuated Leishmania vaccines: a potential strategic alternative

Titel: Role of response gene to complement 32 in diseases
verfasst von: Sonia I. Vlaicu
Cornelia Cudrici
Takahiro Ito
Matthew Fosbrink
Cosmin A. Tegla
Violeta Rus
Petru A. Mircea
Horea Rus
Publikationsdatum: 01.04.2008
Verlag: Birkhäuser-Verlag
Erschienen in: Archivum Immunologiae et Therapiae Experimentalis / Ausgabe 2/2008
Print ISSN: 0004-069X
Elektronische ISSN: 1661-4917
DOI: https://doi.org/10.1007/s00005-008-0016-3

Weitere Artikel der Ausgabe 2/2008

Live attenuated Leishmania vaccines: a potential strategic alternative

Mini-Review

Current advances in the management of urticaria

Review

Mechanisms regulating the development and function of natural regulatory T cells

Review

The role of B lymphocytes as antigen-presenting cells

Review

Quantification of the CD8+ T cell response against a mucin epitope in patients with breast cancer

Open Access
Original Article

1-Methylnicotinamide and nicotinamide: two related anti-inflammatory agents that differentially affect the functions of activated macrophages

Open Access
Original Article